Literature DB >> 20450160

Dihydropyrimidinone positive modulation of delta-subunit-containing gamma-aminobutyric acid type A receptors, including an epilepsy-linked mutant variant.

Ryan W Lewis1, John Mabry, Jason G Polisar, Kyle P Eagen, Bruce Ganem, George P Hess.   

Abstract

Gamma-aminobutyric acid type A receptors (GABA(A) receptors) are ligand-gated chloride channels that play a central role in signal transmission within the mammalian central nervous system. Compounds that modulate specific GABA(A) receptor subtypes containing the delta-subunit are scarce but would be valuable research tools and starting points for potential therapeutic agents. Here we report a class of dihydropyrimidinone (DHPM) heterocycles that preferentially potentiate peak currents of recombinant GABA(A) receptor subtypes containing the delta-subunit expressed in HEK293T cells. Using the three-component Biginelli reaction, 13 DHPMs with structural features similar to those of the barbiturate phenobarbital were synthesized; one DHPM used (monastrol) is commercially available. An up to approximately 3-fold increase in the current from recombinant alpha1beta2delta receptors was observed with the DHPM compound JM-II-43A or monastrol when co-applied with saturating GABA concentrations, similar to the current potentiation observed with the nonselective potentiating compounds phenobarbital and tracazolate. No agonist activity was observed for the DHPMs at the concentrations tested. A kinetic model was used in conjunction with dose-dependent measurements to calculate apparent dissociation constant values for JM-II-43A (400 muM) and monastrol (200 microM) at saturating GABA concentrations. We examined recombinant receptors composed of combinations of subunits alpha1, alpha4, alpha5, alpha6, beta2, beta3, gamma2L, and delta with JM-II-43A to demonstrate the preference for potentiation of delta-subunit-containing receptors. Lastly, reduced currents from receptors containing the mutated delta(E177A) subunit, described by Dibbens et al. [(2004) Hum. Mol. Genet. 13, 1315-1319] as a heritable susceptibility allele for generalized epilepsy with febrile seizures plus, are also potentiated by these DHPMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450160      PMCID: PMC5026497          DOI: 10.1021/bi100119t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  61 in total

Review 1.  Structure, pharmacology, and function of GABAA receptor subtypes.

Authors:  Werner Sieghart
Journal:  Adv Pharmacol       Date:  2006

Review 2.  Inhibitory ligand-gated ion channels as substrates for general anesthetic actions.

Authors:  A Zeller; R Jurd; S Lambert; M Arras; B Drexler; C Grashoff; B Antkowiak; U Rudolph
Journal:  Handb Exp Pharmacol       Date:  2008

3.  GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts.

Authors:  K F Haas; R L Macdonald
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

4.  Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors.

Authors:  Sally-Anne Thompson; Peter B Wingrove; Linda Connelly; Paul J Whiting; Keith A Wafford
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors.

Authors:  Hua-Jun Feng; Jing-Qiong Kang; Luyan Song; Leanne Dibbens; John Mulley; Robert L Macdonald
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

7.  Combining Biginelli multicomponent and click chemistry: generation of 6-(1,2,3-triazol-1-yl)-dihydropyrimidone libraries.

Authors:  Bogdan Khanetskyy; Doris Dallinger; C Oliver Kappe
Journal:  J Comb Chem       Date:  2004 Nov-Dec

8.  alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids.

Authors:  N Zheleznova; A Sedelnikova; D S Weiss
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

9.  Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.

Authors:  K A Wafford; M B van Niel; Q P Ma; E Horridge; M B Herd; D R Peden; D Belelli; J J Lambert
Journal:  Neuropharmacology       Date:  2008-08-13       Impact factor: 5.250

10.  Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits.

Authors:  Wulf Hevers; Stephen H Hadley; Hartmut Lüddens; Jahanshah Amin
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

View more
  8 in total

1.  A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.

Authors:  M L Jensen; K A Wafford; A R Brown; D Belelli; J J Lambert; N R Mirza
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 2.  Use of multicomponent reactions in developing small-molecule tools to study GABAA receptor mechanism and function.

Authors:  Ryan W Lewis; George P Hess; Bruce Ganem
Journal:  Future Med Chem       Date:  2011-02       Impact factor: 3.808

3.  Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.

Authors:  H-J Feng; Y Jounaidi; M Haburcak; X Yang; S A Forman
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Screening of metal ions and organocatalysts on solid support-coupled DNA oligonucleotides guides design of DNA-encoded reactions.

Authors:  Marco Potowski; Florian Losch; Elena Wünnemann; Janina K Dahmen; Silvia Chines; Andreas Brunschweiger
Journal:  Chem Sci       Date:  2019-11-01       Impact factor: 9.825

5.  Synthesis, crystal structure and antibacterial studies of dihydropyrimidines and their regioselectively oxidized products.

Authors:  Alakbar E Huseynzada; Christian Jelch; Haji Vahid N Akhundzada; Sarra Soudani; Cherif Ben Nasr; Aygun Israyilova; Filippo Doria; Ulviyya A Hasanova; Rana F Khankishiyeva; Mauro Freccero
Journal:  RSC Adv       Date:  2021-02-03       Impact factor: 3.361

6.  The Evaluation of DHPMs as Biotoxic Agents on Pathogen Bacterial Membranes.

Authors:  Barbara Gawdzik; Paweł Kowalczyk; Dominik Koszelewski; Anna Brodzka; Joanna Masternak; Karol Kramkowski; Aleksandra Wypych; Ryszard Ostaszewski
Journal:  Membranes (Basel)       Date:  2022-02-18

7.  An efficient synthesis of 4,5-diaryl-3,4-dihydropyrimidin-2(1H)-one via a cesium carbonate-promoted direct condensation of 1-aryl-2-propanone with 1,1'-(arylmethylene)diurea.

Authors:  Yi-Cong Guo; Xuan-Di Song; Wei Deng; Weidong Rao; Haiyan Xu; Zhi-Liang Shen
Journal:  RSC Adv       Date:  2020-08-14       Impact factor: 4.036

8.  The Influence of AA29504 on GABAA Receptor Ligand Binding Properties and Its Implications on Subtype Selectivity.

Authors:  Sylvia Sikstus; Ali Y Benkherouf; Sanna L Soini; Mikko Uusi-Oukari
Journal:  Neurochem Res       Date:  2021-11-02       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.